Akinetic mutism and progressive supranuclear palsy-like syndrome after the shunt of an obstructive hydrocephalus. Successful treatment with bromocriptine: 2 Cases;Mutisme akinetique et pseudo-paralysie supranucleaire progressive secondaires a la derivation d'une hydrocephalie obstructive. Effet benefique de la bromocriptine: 2 Cas

Revue Neurologique

Volumn 156, Issue 4, 2000, Pages 380-383

  Aidi, S ^a   Elalaoui Faris, M ^a   Benabdeljlil, M ^a   Benomar, A ^a   Chaoui, M ^a   Chkili, T ^a  

^a IBN SINA HOSPITAL   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; ANTIPARKINSON AGENT;

ADULT; AKINETIC MUTISM; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID SHUNTING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HUMAN; HYDROCEPHALUS; PROGRESSIVE SUPRANUCLEAR PALSY; SYNDROME DELINEATION; TREATMENT OUTCOME; ATROPHY; BRAIN VENTRICLE PERITONEUM SHUNT; HOSPITALIZATION; MALE; MESENCEPHALON; NEUROSURGERY; PATHOLOGY; RADIOGRAPHY;

ADULT; AKINETIC MUTISM; ANTIPARKINSON AGENTS; ATROPHY; BROMOCRIPTINE; HUMANS; HYDROCEPHALUS; MALE; MESENCEPHALON; NEUROSURGICAL PROCEDURES; SEVERITY OF ILLNESS INDEX; SUPRANUCLEAR PALSY, PROGRESSIVE; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULOPERITONEAL SHUNT;

EID: 0034057592     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. AGGARWAL S, CHILDERS MK, JIMENEZ D. (1997). Use of carbidopa-Levodopa in a patient with hydrocephalus and frozen movement. Brain Injury, 11: 831-836.
2. ANDERSON B. (1992). Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine. J.Neurosurg, 76: 152-155.
3. BERGER L, GAUTHIER S, LEBLANC R. (1985). Akinetic mutism and parkinsonism associated with obstructive hydrocephalus. Can J Neurol Sci, 12: 255-258.
4. rd ventricle (with a report of the associated disturbance of brain potentiels). Brain, 64: 273-290.
5. LIU XH, KATO H, CHEN T, KATO K, ITAYAMA Y. (1995). Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. Journal of the Neurological Sciences, 129: 9-14.
6. MESSERT B, HENKE TK, LANGHEIM W. (1966). Syndrome of akinetic mutism associated with obstructive hydrocephalus. Neurology, 16: 635-649.
7. MOSER A, FREYBERGER HJ, BRUCKMANN H, KOMPF D. (1995). Akinetic mutism in decompensated triventricular hydrocephalus. Fortschr Neurol Psychiatr, 63 (6): 248-251.
8. ROSS ED, STEWART RM. (1981). Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology, 31: 1435-1439.
9. UNGERSTEDT U. (1974). Functional dynamics of central monsamine pathways, in Schmitt FO, Worden FG (eds): The neurosciences Thid Study Program. Cambridge, Mass: MIT Press. pp 979-988.
10. VOLKOW ND, FOWLER JS, GATLEY SJ, WANG GJ, DING YS, DEVEY S. (1996). Pet evaluation of the dopamine system of the humain brain. The journal of Nuclear Medicine 37, 7: 1242-1256.
11. WATAHIKI Y, NARITA S, KURAHASHI K, TANAKA T, MATSUNAGA M. (1987). Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl. No-To-Shinke (Jpn), 39 (10): 977-982.